Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AK002 in Healthy Participants
Clinical trial NCT02859701 · COMPLETED
Trial details
- NCT number
- NCT02859701
- Sponsor
- Allakos Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-05-17
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.